SIAT Research
  • Mar 03, 2026
    Magnetofluids: A Breakthrough in Overcoming Clinical Challenges of Left Atrial Appendage Occlusion
    A study published in Nature on March 4 and led by Prof. XU Tiantian's team from the Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences, together with Prof. PAN Xiangbin's ... In left atrial appendage occlusion, traditional interventional techniques are confronted with challenges such as poor adaptability between metallic devices and the left atrial appendage, incomplete...
  • Mar 02, 2026
    Largest High-precision 3D Facial Database Built in China, Enabling More Lifelike Digital Humans
    In a study published in IEEE Transactions on Circuits and Systems for Video Technology, a research team led by Prof. SONG Zhan from the Shenzhen Institutes of Advanced Technology of the Chinese Aca... In an elderly-care themed skit during the 2026 Spring Festival Gala (Chunwan), a lifelike android was modeled on actress CAI Ming. Why are humanoid robots becoming so lifelike and indistinguishable...
  • Jan 28, 2026
    AAVLINK: A potent DNA-recombination method for large cargo delivery in gene therapy
    AAVLINK allows flexible gene segmentation design, achieves high-efficiency full-length gene reconstitution, and markedly reduces the production of aberrant truncated proteins compared with conventi... Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying gene cargoes because of their superior gene segmentation flexibility and...
  • Jan 22, 2026
    Knowledge-Driven Autonomous Materials Research via Collaborative Multi-Agent and Robotic System
    In a study published in Matter, a research team led by Prof.YU Xuefeng from the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences developed a knowledge-driven mul... Traditional process to discover new materials is complex, time-consuming, and costly, which often requires years of a sustained effort. Recent advances in large language models (LLMs) have demonstr...
  • Jan 19, 2026
    Composite Superionic Electrolytes for Pressure-less Solid-State Batteries Achieved by Continuously Perpendicularly Aligned 2D Pathways
    In a study published in Nature Nanotechnology, a team led by Prof. CHENG Hui-Ming and PENG Jing from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences, along with Pr... Solid electrolytes are promising candidates for safe, high-energy battery systems. Composite solid electrolytes, in particular, hold the potential to combine high ionic conductivity with stable ele...
  • Jan 14, 2026
    Amino Acid Residue-driven Nanoparticle Targeting of Protein Cavities Beyond Size Complementarity
    In a study published in the Journal of the American Chemical Society, led by Prof. LI Yang at the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, elucidated the molecular m... Cavities at protein-protein interaction interfaces are often considered "undruggable" because their shallow or large geometries hinder the stable binding by small molecules. A study published in Jo...
  • Jan 12, 2026
    New AI Algorithm Enables Scientific Monitoring of "Blue Tears"
    In a study published in Ecological Informatics, a team led by Prof. LI Jianping from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences, along with the collaborators ... In recent years, "blue tears" chasing has become a popular tourism activity along coasts to witness the spectacular natural phenomenon. However, the occurrence and movement of algal blooms are unpr...
  • Jan 09, 2026
    Overcoming Drug Resistance by Disrupting HDAC1 Condensates in Glioblastoma
    Researchers discovered that TMZ treatment induces the formation of HDAC1-CTCF condensates in GBM cells, leading to chromatin remodeling and enhanced DNA repair activity, thereby promoting acquired ... Glioblastoma (GBM) is one of the most common and aggressive primary brain tumors in adults, with an extremely poor prognosis and a median overall survival typically less than two years. Temozolomid...